Dolutegravir-based ART with isoniazid was safe and effective for tuberculosis prevention in ART-naïve HIV patients, leading to rapid viral suppression. The study reported minimal adverse events, with ...

In a recent study published in the journal Clinical Infectious Diseases, researchers reported on the treatment of rifampin-resistant tuberculosis in the United States (U.S.) using the Food and Drug ...

Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs, while others may warrant more aggressive therapy, according to the findings of a new ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...

Working toward more effective tuberculosis (TB) vaccines, researchers have developed two strains of mycobacteria with 'kill switches' that can be triggered to stop the bacteria after they activate an ...

In patients with rifampin-resistant tuberculosis, all-oral treatment regimens that are more effective, shorter, and have a more acceptable side-effect profile than current regimens are needed. We ...

To reduce the risk of TB, practice good hygiene, get vaccinated if appropriate, and seek regular screenings if you’re at higher risk. Tuberculosis (TB) is an infectious disease caused by the bacterium ...

Superspreading became a familiar concept to many during the COVID-19 pandemic. Prior studies examining infectious disease ...

Mycobacterium tuberculosis (MTB) and Mycobacterium avium complex (MAC) are two distinct types of bacteria that can cause infections in the lungs and other parts of the body. Belonging to the same ...